Patient engagement is a major component of Stage 2 of the Meaningful Use program, but patient portal vendors vary in their ability to meet the requirements, according to a new study released Sept. 17 by Orem, Utah-based KLAS Research.

read more

Source: Study: Not all portal vendors adequately support Meaningful Use Stage 2